Less than two months after being acquired by BGI-Shenzhen, Complete Genomics has started joint technology development with its new parent, is supporting BGI-led research projects, and has begun to integrate its sales force with BGI as it continues to serve existing customers of its human whole-genome sequencing service.

Longer term, the Mountain-View, Calif.-based company – now a wholly-owned subsidiary of BGI – plans to collaborate closely with BGI Health, BGI's clinical arm, to provide sequencing services to the clinical market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.